The maker of EpiPens offered patients more help to pay for its costly emergency allergy shots but didn’t budge Thursday on the $608 price. The announcement from Mylan N.V. triggered a new round of ...
Mylan is bulking up programs that help patients pay for its EpiPen emergency allergy treatment after weathering heated criticism about an average cost that has climbed more than 600 percent over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results